Schroder Investment Management Group’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-37,701
| Closed | -$843K | – | 1267 |
|
|
2019
Q1 | $843K | Buy |
37,701
+13,712
| +57% | +$307K | ﹤0.01% | 935 |
|
|
2018
Q4 | $574 | Sell |
23,989
-20,147
| -46% | -$482 | ﹤0.01% | 979 |
|
|
2018
Q3 | $1.2M | Hold |
44,136
| – | – | ﹤0.01% | 897 |
|
|
2018
Q2 | $1.21M | Buy |
44,136
+14,760
| +50% | +$404K | ﹤0.01% | 896 |
|
|
2018
Q1 | $935K | Buy |
29,376
+12,865
| +78% | +$409K | ﹤0.01% | 962 |
|
|
2017
Q4 | $624K | Sell |
16,511
-22,556
| -58% | -$852K | ﹤0.01% | 1065 |
|
|
2017
Q3 | $961K | Buy |
+39,067
| New | +$961K | ﹤0.01% | 987 |
|